JP2008531713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531713A5 JP2008531713A5 JP2007558191A JP2007558191A JP2008531713A5 JP 2008531713 A5 JP2008531713 A5 JP 2008531713A5 JP 2007558191 A JP2007558191 A JP 2007558191A JP 2007558191 A JP2007558191 A JP 2007558191A JP 2008531713 A5 JP2008531713 A5 JP 2008531713A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- group
- alkyl
- amino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- NUAQIRUAZSJTAI-YRPZDAAMSA-N O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@H](N)CC(C)C)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@H](N)CC(C)C)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 NUAQIRUAZSJTAI-YRPZDAAMSA-N 0.000 claims 3
- 125000002877 alkyl aryl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 230000010933 acylation Effects 0.000 claims 1
- 238000005917 acylation reaction Methods 0.000 claims 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- -1 carboxyl ester Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims 1
- 125000005309 thioalkoxy group Chemical group 0.000 claims 1
- 0 CC(C)CC(C(NC(C(c(cc1Cl)ccc1OC(C1OC(C(C2O)OC(CC3(C)*)OC(C)C3O)OC(CO)C2O)=CC(C(C(NC)=O)NC(C(CC(N)=O)N2)=O)=CC1Oc1ccc(C(C(C(*C(C(C)=O)c3c(-c(cc(C4)cc5)c5O)c(O)c(*)c(O)c3)=O)NC4=O)OC)cc1Cl)O)C2=O)=O)IN Chemical compound CC(C)CC(C(NC(C(c(cc1Cl)ccc1OC(C1OC(C(C2O)OC(CC3(C)*)OC(C)C3O)OC(CO)C2O)=CC(C(C(NC)=O)NC(C(CC(N)=O)N2)=O)=CC1Oc1ccc(C(C(C(*C(C(C)=O)c3c(-c(cc(C4)cc5)c5O)c(O)c(*)c(O)c3)=O)NC4=O)OC)cc1Cl)O)C2=O)=O)IN 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65727405P | 2005-02-28 | 2005-02-28 | |
| PCT/US2006/007337 WO2006094082A2 (en) | 2005-02-28 | 2006-02-27 | Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035926A Division JP2009102448A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531713A JP2008531713A (ja) | 2008-08-14 |
| JP2008531713A5 true JP2008531713A5 (enExample) | 2009-04-09 |
Family
ID=36941795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558191A Pending JP2008531713A (ja) | 2005-02-28 | 2006-02-27 | 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド |
| JP2009035926A Pending JP2009102448A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035926A Pending JP2009102448A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20070185015A1 (enExample) |
| EP (1) | EP1868630A2 (enExample) |
| JP (2) | JP2008531713A (enExample) |
| AU (1) | AU2006218533A1 (enExample) |
| BR (1) | BRPI0607695A2 (enExample) |
| CA (1) | CA2599297A1 (enExample) |
| MX (1) | MX2007010500A (enExample) |
| WO (1) | WO2006094082A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1818340A4 (en) | 2004-11-29 | 2009-02-25 | Univ Nagoya Nat Univ Corp | ANTIBIOTIC MONOMERS GLYCOPEPTIDE DERIVATIVES |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
| TW200808818A (en) | 2006-05-26 | 2008-02-16 | Shionogi & Co | Glycopeptide antibiotic derivatives |
| KR20100109936A (ko) * | 2007-12-26 | 2010-10-11 | 리드 테라퓨틱스, 인크. | 항박테리아제로서의 신규한 반(半)-합성 글리코펩티드 |
| WO2010048340A2 (en) * | 2008-10-24 | 2010-04-29 | Lead Therapeutics, Inc. | Novel semi-synthetic glycopeptides as antibacterial agents |
| GB2465863A (en) * | 2008-12-05 | 2010-06-09 | Lead Therapeutics Inc | Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections |
| WO2011140009A1 (en) * | 2010-05-04 | 2011-11-10 | Biomarin Pharmaceutical Inc. | Methods of using semi-synthetic glycopeptides as antibacterial agents |
| IL270686B (en) * | 2017-05-22 | 2022-09-01 | Insmed Inc | Derivatives of glycopeptides and their uses |
| CN107987131B (zh) * | 2017-11-16 | 2021-03-09 | 上海来益生物药物研究开发中心有限责任公司 | 一组具有抗耐药性细菌活性的化合物、其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698327A (en) * | 1985-04-25 | 1987-10-06 | Eli Lilly And Company | Novel glycopeptide derivatives |
| GB8522574D0 (en) * | 1985-09-12 | 1985-10-16 | Lepetit Spa | Amides of teicoplanin compounds |
| US5500410A (en) * | 1989-03-29 | 1996-03-19 | Gruppo Lepetit S.P.A. | Substituted alkylamide derivatives of teicoplanin |
| US5840684A (en) * | 1994-01-28 | 1998-11-24 | Eli Lilly And Company | Glycopeptide antibiotic derivatives |
| US5488131A (en) * | 1994-03-23 | 1996-01-30 | California Institute Of Technology | Synthesis of compounds with predetermined chirality |
| JP3031202B2 (ja) * | 1994-08-08 | 2000-04-10 | 株式会社デンソー | 携帯無線局 |
| US5919756A (en) * | 1996-06-28 | 1999-07-06 | Eli Lilly And Company | Amides |
| US5974507A (en) * | 1997-04-14 | 1999-10-26 | International Business Machines Corporation | Optimizing a cache eviction mechanism by selectively introducing different levels of randomness into a replacement algorithm |
| US6026445A (en) * | 1997-11-17 | 2000-02-15 | International Business Machines Corporation | System and method for saving and reusing recently acquired name to address mappings |
| BRPI9914221B8 (pt) * | 1998-12-23 | 2021-05-25 | Advanced Medicine Inc | derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos |
| US6699836B2 (en) * | 1999-04-02 | 2004-03-02 | The Trustees Of Princeton University | Vancomycin analogs |
| US6498238B1 (en) * | 1999-05-19 | 2002-12-24 | Princeton University | Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| US20030008812A1 (en) * | 2001-02-02 | 2003-01-09 | Christensen Burton G. | Glycopeptide derivatives |
| US7348309B2 (en) * | 2001-03-30 | 2008-03-25 | Wisconsin Alumni Research Foundation | Glycorandomization and production of novel vancomycin analogs |
| KR20060091049A (ko) * | 2002-08-30 | 2006-08-17 | 케이.유.루벤 리서치 앤드 디벨럽먼트 | 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용 |
| AU2003287605A1 (en) * | 2002-11-12 | 2004-06-03 | Enzon Pharmaceuticals, Inc. | Polymeric prodrugs of vancomycin |
| US7521418B2 (en) * | 2003-05-27 | 2009-04-21 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| US7368422B2 (en) * | 2005-02-28 | 2008-05-06 | Novartis Vaccines And Diagnostics Inc. | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
| US7461206B2 (en) * | 2006-08-21 | 2008-12-02 | Amazon Technologies, Inc. | Probabilistic technique for consistency checking cache entries |
-
2006
- 2006-02-24 US US11/361,682 patent/US20070185015A1/en not_active Abandoned
- 2006-02-27 BR BRPI0607695-5A patent/BRPI0607695A2/pt not_active IP Right Cessation
- 2006-02-27 CA CA002599297A patent/CA2599297A1/en not_active Abandoned
- 2006-02-27 MX MX2007010500A patent/MX2007010500A/es not_active Application Discontinuation
- 2006-02-27 EP EP06721134A patent/EP1868630A2/en not_active Withdrawn
- 2006-02-27 AU AU2006218533A patent/AU2006218533A1/en not_active Abandoned
- 2006-02-27 JP JP2007558191A patent/JP2008531713A/ja active Pending
- 2006-02-27 WO PCT/US2006/007337 patent/WO2006094082A2/en not_active Ceased
-
2008
- 2008-11-10 US US12/268,364 patent/US20090131304A1/en not_active Abandoned
-
2009
- 2009-02-18 JP JP2009035926A patent/JP2009102448A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69809959T2 (de) | Neue taxanderivate | |
| JP2008531702A5 (enExample) | ||
| JP2005526857A5 (enExample) | ||
| RU2005128190A (ru) | Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации | |
| JP2016510323A5 (enExample) | ||
| EP2698375A3 (en) | TGR5 modulators and method of use thereof | |
| JP2009511508A5 (enExample) | ||
| CA2472341A1 (en) | Phosphorus-containing compounds & uses thereof | |
| JP5068813B2 (ja) | 新規なベンゾチアジノン誘導体、及び抗菌剤としてのその使用 | |
| JP2008511601A5 (enExample) | ||
| RU2006135541A (ru) | Производные аминокислот | |
| JP2008531713A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| JP2007500222A5 (enExample) | ||
| JP2006515866A5 (enExample) | ||
| US9034894B2 (en) | Derivate, preparation method and use of 10-methoxycamptothecin | |
| Foroumadi et al. | Synthesis, in vitro‐Antimycobacterial Activity and Cytotoxicity of Some Alkyl α‐(5‐aryl‐1, 3, 4‐thiadiazole‐2‐ylthio) acetates | |
| CA2436958A1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
| RU2003134629A (ru) | Соединения цефема | |
| JP2025072404A (ja) | コンジュゲート | |
| JPWO2021133896A5 (enExample) | ||
| JP2008531701A5 (enExample) | ||
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| US20170029388A1 (en) | Treatment of Neurodegenerative Diseases with Asparagine Endopeptidase (AEP) Inhibitors and Compositions Related Thereto | |
| JP2008500363A5 (enExample) |